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Renal cell carcinoma (RCC) is infamous for its unpredictable behavior and metastatic potential. We report a case of a patient with
a complex history of multifocal renal cell carcinoma and chronic lymphocytic leukemia (CLL), who subsequently developed a
parotid mass. Total parotidectomy revealed this mass to be an additional site of metastasis which had developed 19 years after his
initial diagnosis of RCC.
1.CaseReport
An 82-year-old male presented with a right preauricular
mass for an 18-month duration. The mass was nontender
and had grown rapidly in the previous 6 months. His past
medical history is notable for chronic lymphocytic leukemia
(CLL)diagnosedin2004whichwasnottreated.Additionally,
he has a history of right-sided RCC status post partial
nephrectomy in 1990 as well as a tumor which developed
in the left adrenal gland in 2007 for which he underwent
total adrenalectomy and nephrectomy. Pathology from this
excision was consistent with RCC, though it is unclear if this
represented a metastatic lesion from his original site or a
second primary tumor.
CT scan of the neck revealed a 4 by 3.5cm enhancing
lesion in the right parotid gland involving the superﬁcial and
deep aspects of the gland (Figure 1). In order to diﬀerentiate
between an intraparotid lymphoma and other etiologies of
parotidtumors,ﬁneneedleaspiration(FNA)wasperformed.
The specimen contained blood with increased amount of
monotonous small-sized lymphocytes. A portion of the
specimen was sent for ﬂow cytometry analysis and result
was consistent with chronic lymphocytic leukemia. Given
the patient’s medical history and the sanguineous nature of
the needle aspirate, a broad diﬀerential diagnosis, including
RCC, was still being considered.
The patient underwent total parotidectomy. Once the
lesion was encountered, frozen section analysis revealed
metastatic renal cell carcinoma. The tumor encased the
main trunk of the facial nerve and had a robust angiogenic
response. Total parotidectomy was performed with facial
nervepreservation.Permanentpathologicspecimenrevealed
metastatic renal cell carcinoma, clear cell type (Figure 2).
The patient was treated postoperatively with radiation to
the parotid bed. Shortly after the radiation treatment the
patient noted several lesions along the surgical bed. Biopsy
performed of these lesions revealed RCC. He underwent
a brief course of palliative chemo and is currently living
comfortablywithdisease.Nofurtherinterventionisplanned.
2. Discussion
Renal cell carcinoma (RCC) is infamous for its unpredictable
behavior and metastatic potential. Although the most com-
mon sites for RCC metastasis are the lung, lymph nodes,
bone, liver, adrenal, and brain, this neoplasm may involve
any organ including the parotid as an unusual metastatic
site [1, 2]. It is well described in the literature to metastasize
to regions in the head and neck. In a case series of 65
patients with RCC presenting as metastatic lesion to the
head and neck, 47 patients had cervical lymphadenopathy,2 Case Reports in Medicine
Figure 1: Preoperative CT scan.
Figure 2: The tumor is characterized by sheets of round to
polygonal cells interspersed with numerous thin-walled blood
vessels (Hematoxylin-eosin, ×100).
and 18 patients presented at extranodal sites including the
skin, thyroid, skull, pharynx, and lip, with no case in the
parotid gland [3]. Moudouni et al. reported a 10-year lapse
between the initial diagnoses of RCC and the metastasis to
the submaxillary gland [4]. A recent review of all cases of
RCC metastatic to the parotid gland published in the English
language literature revealed a total of 25 such cases [5]. In 14
of these25 cases,parotid metastasiswastheinitial presenting
sign of malignancy in the kidney [5]. The time intervals from
the removal of the kidney tumor to the appearance of the
parotid mass ranged from several months to 10 years [5].
Though FNA is often utilized preoperatively in evalu-
ating salivary gland malignancies, it is important to realize
that there is a high false negative rate in evaluation of
metastatic RCC to the parotid gland. Park and Hlivko
reported a 33% incidence of false negatives or nondiagnostic
results in their series [5]. Clear cell RCC is a challenging
diagnosis for the pathologist as the diﬀerential diagnosis
includes benign tumors, such as oncocytic hyperplasia,
oncocytoma, myoepithelioma, pleomorphic adenoma, and
sebaceous adenoma [6]. Immunohistochemical analysis is
essentialformakingthediagnosis.Markerssuchasvimentin,
CD-10, and EMA have been found to have particular utility
in aiding to distinguish RCC from other neoplasms which
may present in a similar manner.
The mechanism by which a renal cell carcinoma reaches
the parotid gland is via hematogeneous spread. In fact,
renal cell carcinomas are hypervascular tumors associated
with multiple arteriovenous shunts due to release of VEGF
and other angiogenic factors. Considering the fact that the
kidneys receive 25% of circulating blood volume, renal cell
carcinoma has a high hematogeneous spreading potential
[7].
Another aspect of this case which warrants consideration
isthefactthatthepatienthadbothRCCandCLL.Nishikubo
et al. reported on a series of 8 patients in which they found
an association between renal cell carcinoma and lymphoid
malignancies[8].Infactitwasdeterminedthattheincidence
of renal cell carcinoma and lymphoid malignancy occurring
in the same patient is higher than expected in the general
population by chance alone. Possible explanations for the
relationship were hypothesized to be a genetic mutation
common to both malignancies, environmental exposure, or
an immunomodulatory eﬀect of the ﬁrst tumor causing a
predisposition to the second.
The current case presented a diﬃcult diagnostic as well
as intraoperative challenge. First, establishing a diagnosis of
RCC was not possible on FNA due to the vascular nature
of the tumor. Given the patient’s history of CLL, there was
increased suspicion for intraparotid CLL. The treatment for
this entity is chemotherapy instead of parotidectomy. Thus,
when FNA was nondiagnostic, an open approach to the
parotid was taken and frozen section analysis was performed
to rule out lymphoma. The second aspect of this case which
presented a challenge was the highly vascular nature of the
tumor. Facial nerve preservation was still possible; however
meticulous hemostasis was required during the dissection.
3. Conclusion
D o c u m e n t a t i o no fac a s eo fm e t a s t a t i cr e n a lc e l lc a r c i n o m a
to the parotid gland is important to note as it serves to
remind clinicians that any patient with a history of renal cell
carcinoma is at risk for late metastases; including sites within
the head and neck. Standard diagnostic measures such as
FNA may not yield a deﬁnitive diagnosis and patients must
be counseled accordingly. Thus, a high index of suspicion for
metastatic disease should be given for patients with a history
of renal cell carcinoma. Based on our literature review, this
case represents the longest duration for recurrence of RCC
metastatic to the parotid gland.
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